Impact of Pharmacist-Led Microbiology Result Follow-Up After Hospital Discharge
Author Information
Author(s): Van Abel Amy L. PharmD, RPh, Virk Abinash MD, Cole Kristin MS, Lane Trudi RPh, MS, Osmon Douglas MD, Pertzborn Margaret PharmD, Schreier Diana PharmD, Teaford Hilary PharmD, MHI, Willis Courtney PharmD, Woods Anna PharmD, Rivera Christina G. PharmD, RPh
Primary Institution: Mayo Clinic
Hypothesis
The study aims to determine the rate of clinical actions taken post-discharge on updated microbiology results by an ID pharmacist-led team.
Conclusion
Pharmacist-led review of microbiology results post-discharge effectively addressed abnormal results during the transition of care.
Supporting Evidence
- 29% of patient encounters required pharmacist intervention.
- Median time from test update to clinical review was 27.2 hours.
- 28% of interventions had the highest severity ratings indicating potential patient harm.
Takeaway
Pharmacists checked test results after patients left the hospital to make sure they got the right treatment, helping to keep them safe.
Methodology
Retrospective cohort study involving adult patients at four Mayo Clinic sites from 1/1/2019 to 2/28/2023.
Potential Biases
Dependence on accurate documentation and potential for subjective severity ratings.
Limitations
The study was retrospective, conducted within one health system, and may have selection bias.
Participant Demographics
{"age":{"mean":59.7,"sd":15.9},"sex":{"female":2727,"male":4064,"nonbinary":1},"race":{"white":5919,"black_or_african_american":269,"asian":129,"hispanic_or_latino":257,"other":153,"unknown":65}}
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, 28.0–30.2
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website